Industry Support Of Societies Under Fire

An editorial accompanying a JAMA thyroid drug study criticized private-sector funding of professional associations. A recent editorial in JAMA-Journal of the American Medical Association that detailed the events surrounding the suppression of a pharmaceutical study has drawn attention to the relationship between scientific professional societies and sponsorship by private companies (D. Rennie, JAMA, 277:1238-43, 1997). In its April 16 issue, the journal published a long-subdued study that show

Written byKaren Young Kreeger

| 8 min read

Save for Later

Listen with Speechify

0:00

8:00

An editorial accompanying a JAMA thyroid drug study criticized private-sector funding of professional associations.

A recent editorial in JAMA-Journal of the American Medical Association that detailed the events surrounding the suppression of a pharmaceutical study has drawn attention to the relationship between scientific professional societies and sponsorship by private companies (D. Rennie, JAMA, 277:1238-43, 1997). In its April 16 issue, the journal published a long-subdued study that showed that a popular thyroid drug called Synthroid was no more potent than less costly formulations (B.J. Dong et al., JAMA, 277:1205-13, 1997). The editorial, which ran in the same issue, decried the growing trend of industry-sponsored research and called for professional societies to reexamine their relationship with the private sector. Yet society officials point out that there are already many conflict-of-interest safeguards in place.

RESTRICTIONS: JAMA deputy editor Drummond Rennie contends that to maintain credibility, societies should set limits on contributions from ...

Interested in reading more?

Become a Member of

Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!

Join for free today

Already a member? Login Here